Respiratory Drop in pharma franchise in Manipur

Respiratory Drop in PCD pharma franchise in Jaipur

Respiratory Drop in top pharma company in Bhopal

Respiratory Drop in pcd pharma supplier in Gwalior

Respiratory Drop in phama franchise company in India
Respiratory Drop in phama distributor in Puducherry

Home/Products /ambroxol-7-point-5mg-levosalbutamol-0-point-25mg-guaifenesin-12-point-5mg-drop

Cufsniff LS Drop

Composition : Ambroxol (7.5mg) + Levosalbutamol (0.25mg) + Guaifenesin (12.5mg)

Dosage Form : Drop

Packaging Type : with Carton and Dropper

Packaging : 15 ml

Price : ₹87/-

Cufsniff LS Drop combines Ambroxol (7.5mg), Levosalbutamol (0.25mg), and Guaifenesin (12.5mg) in a single formulation, designed to provide effective relief from respiratory conditions associated with mucus overproduction, coughing, and airway obstruction. Ambroxol acts as a mucolytic agent, thinning and loosening mucus in the airways, making it easier to expel. Levosalbutamol is a bronchodilator that relaxes the airway muscles, improving airflow and easing breathing difficulties. Guaifenesin works as an expectorant, promoting the clearance of mucus from the respiratory tract. Together, these components ensure efficient relief from cough and congestion while improving respiratory comfort.

This formulation is particularly beneficial for managing respiratory conditions like asthma, bronchitis, and chronic obstructive pulmonary disease (COPD), especially when they involve excessive mucus or difficulty in breathing. It provides symptomatic relief by addressing the underlying causes of respiratory discomfort, making it an essential therapy for both acute and chronic respiratory ailments. The liquid drop form is especially convenient for pediatric use, allowing accurate dosing and faster absorption.

Read More

About the Product

Cufsniff LS Drop combines Ambroxol (7.5mg), Levosalbutamol (0.25mg), and Guaifenesin (12.5mg) in a single formulation, designed to provide effective relief from respiratory conditions associated with mucus overproduction, coughing, and airway obstruction. Ambroxol acts as a mucolytic agent, thinning and loosening mucus in the airways, making it easier to expel. Levosalbutamol is a bronchodilator that relaxes the airway muscles, improving airflow and easing breathing difficulties. Guaifenesin works as an expectorant, promoting the clearance of mucus from the respiratory tract. Together, these components ensure efficient relief from cough and congestion while improving respiratory comfort.

This formulation is particularly beneficial for managing respiratory conditions like asthma, bronchitis, and chronic obstructive pulmonary disease (COPD), especially when they involve excessive mucus or difficulty in breathing. It provides symptomatic relief by addressing the underlying causes of respiratory discomfort, making it an essential therapy for both acute and chronic respiratory ailments. The liquid drop form is especially convenient for pediatric use, allowing accurate dosing and faster absorption.

Common side effects may include nausea, vomiting, or a mild headache. Rarely, it may cause drowsiness, dizziness, or mild gastrointestinal discomfort.

Cufsniff LS Drop is indicated for managing wet cough, bronchitis, asthma, and other respiratory conditions associated with mucus production and airway obstruction.

Do not use this medication if allergic to any of its components. Follow the prescribed dosage to avoid side effects and ensure effectiveness.

Store in a cool, dry place away from direct sunlight. Ensure the bottle is tightly closed after use and keep it out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation